Pharmaceuticals
-
Heart risk after breast cancer therapy
Long term breast cancer survivors may face significantly increased cardiovascular disease risks because of the treatments they underwent, Dutch researchers report today. Read more
-
Cannabis medicine hope for pancreatic cancer
Researchers have hailed a “remarkable” research finding that could have a significant impact on people being treated for pancreatic cancer. Read more
-
Undetectable HIV safe for partner
Effective HIV treatment ensures men are not at risk of passing the infection to partners, according to a new analysis. Read more
-
Painkiller danger for dementia
Some popular painkillers may exacerbate the symptoms of dementia. Read more
-
Botulinum based drug to “revolutionise” pain relief
A drug that combines botulinum and opioids could “revolutionise” pain management, according to its UK developers. Read more
-
Heatwave horsefly risk warning
High levels of horseflies amid the human population could test the limits of antibiotics, campaigners warn today. Read more
-
High-dose chemo for neuroblastoma
A new study has looked at long-term outcomes for children with high-risk neuroblastoma treated with high-dose chemotherapy plus autologous stem cell transplantation. Read more
-
Hope for heart regeneration treatment
A treatment that can regenerate the heart after myocardial infarction was unveiled last night. Read more
-
Anticoagulant drugs prevented 4,000 strokes in a year
An increase in the number of people with atrial fibrillation taking anticoagulant drugs helped to prevent 4,000 strokes in England between 2015 and 2016, according to research published today. Read more
-
Anti-miscarriage drug ineffective
There is no evidence of a benefit for a new drug that aims to prevent recurrent miscarriage, a conference has heard. Read more
